reliance on sales in China. At present, the Company’s products are well- received in the Philippines but still could not make up for the slowdown in sales in China. The Company is committed to expanding

in China. The Company is committed to expanding further to other potential countries and is in the process of conducting market feasibility studies in certain markets. Apart from that, the Company was

for the slowdown in sales in China. The Company is committed to expanding further to other potential countries and is in the process of conducting market feasibility studies in certain markets. Apart

received from current investment. 2. Cost of sale , Profit margin In Q2/2017 the company had cost of sale Baht 82.97 million compare with the same period of previous year amount to Baht 68.01 million

period of last year. The increase was mainly driven by positive same store sales growth (SSSG). In addition, the gross profit margin grew consistently, due to more efficient management of the product mix

quarter of 2020, the negative gross margin of hotel operations was THB 4.89 million, equaled to -26.71% of the total revenues from operations. The hotel operations had the negative gross margin increased of

Company has acknowledged the situation and adjusted the strategy and marketing plans accordingly to minimize the impact, by focusing in expanding the customer base and emphasizing in online channel

hemodialysis centers in northeastern and 1 hemodialysis center in western, which patients are increase as continuously to fully capacity. And, continue to focus on expanding hemodialysis center. Medical Vision

29.3% YoY. FSMART has continued the strategic plan of expanding the number of Boonterm kiosk effectively and maintaining the ARPU (average revenue per unit) level efficiently. In 2017, the average ARPU

acknowledged product quality and its attractive lower retailing price as compared to the previous packaging size of a 330 ml. The new energy drink is not only expanding the customer base to younger generations